Cargando…
Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?
PURPOSE OF REVIEW: The highly infectious transmissible disease, the novel SARS-CoV-2, causing the coronavirus disease (COVID-19), has a median incubation time of 5 to 15 days. The symptoms vary from person to person and many are “hidden carriers.” Few people experience immediate reaction and even de...
Autor principal: | Singh, Varsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356139/ https://www.ncbi.nlm.nih.gov/pubmed/32661859 http://dx.doi.org/10.1007/s13668-020-00330-4 |
Ejemplares similares
-
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
por: Mörkl, Sabrina, et al.
Publicado: (2020) -
Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis
por: Kannt, Aimo, et al.
Publicado: (2019) -
Extracellular Vesicles from Hypoxic Adipocytes and Obese Subjects Reduce Insulin‐Stimulated Glucose Uptake
por: Mleczko, Justyna, et al.
Publicado: (2018) -
Urinary Excretion of Niacin Metabolites in Humans After Coffee Consumption
por: Kremer, Jonathan Isaak, et al.
Publicado: (2018) -
Cinnamyl Isobutyrate Decreases Plasma Glucose Levels and Total Energy Intake from a Standardized Breakfast: A Randomized, Crossover Intervention
por: Hochkogler, Christina M., et al.
Publicado: (2018)